News

Switzerland-based Basilea Pharmaceutica has announced that the Scottish Medicines Consortium has accepted Toctino for use within National Health Service Scotland for the treatment of adults with severe chronic

Mr Hanson is a founding partner of Barnard Life Sciences, a healthcare consulting company founded in 2001. From 2004 to 2009, Mr Hanson was a member of the

Tolerx, a biopharmaceutical company, has announced that Defend, the Phase III trial of otelixizumab, an investigational novel targeted immunotherapeutic, has started enrollment of new onset autoimmune type 1

BioImagene has said that its iScan slide scanners address the challenges posed by traditional microscopy by providing a powerful, highly automated and collaborative platform that supports the entire

Azzalure has received the UK approval for the temporary improvement in the appearance of moderate to severe glabellar lines seen at the frown, in adult men and women

The proceeds will be used for the ongoing clinical development of KBPA 101 in nosocomial pneumonia and to advance KBSA 201, a fully human IgG monoclonal antibody against

The agreement permits Barr and Teva to launch generic versions of these Xopenex inhalation solution dosages under terms of a non-exclusive license commencing on February 17, 2013. The

IDM Pharma, a biopharmaceutical company, has announced that the European Commission has formally granted a centralized marketing authorization for Mepact for the treatment of patients with non-metastatic, resectable

Endologix, a developer of minimally invasive therapies for the treatment of vascular disease, has received the FDA approval of the IntuiTrak express delivery system for the Powerlink XL